The Diversatek SafeGuide guidewire recall covers two models that clinics and hospitals should check for: model 1214-02, lot 244736, and model 1214-02D, lots 245290 and 245321. The FDA classified both listings as
Class 2. Together, they cover 3,324 units distributed nationwide. Diversatek asked consignees to discard affected units after reporting that guidewires from the affected lots were more flexible than expected.
The FDA posted both listings on November 20, 2026, under event ID 100170. Model 1214-02 is listed as recall
Z-0515-2027; model 1214-02D is listed as
Z-0516-2027. The firm initiated the
recalls on October 5, 2026, and both FDA listings show the status as open and classified.
The SafeGuide Marked Spring Tip Guidewire is used with
esophageal dilators during dilation procedures. Diversatek says its SafeGuide products support esophageal dilation and reprocessing workflows, and its product information lists measurement bands at 20 cm increments and a 210 cm length for both recalled models. The manufacturer describes the spring tip as built to flex when it meets resistance.
Products and next steps
The FDA lists both products as esophageal dilators under product code KNQ, with 510(k) number K924646. Diversatek Healthcare, based in Milwaukee, Wisconsin, is the recalling firm.
| Identifier | Model 1214-02 | Model 1214-02D |
| Lot number | 244736 | 245290, 245321 |
| UDI/DI | 00816734020975 | 00816734021507 |
| Recall number | Z-0515-2027 | Z-0516-2027 |
| Quantity in commerce | 228 units | 3,096 units |
| Case quantity | 2 per case | 6 per case |
Diversatek’s product information describes model 1214-02 as reusable and model 1214-02D as disposable; the FDA recall listings describe both as reusable.
Facilities should check inventory, purchasing records and storage areas for both models and all three lot numbers. If stock matches, follow the firm’s instruction to discard it. Procurement teams can match the UDI/DI numbers in the table against supplier records and device labels. The FDA listing gives Laura L. Boll as the contact at 414-755-4806. Share the recall notice and identifiers with staff responsible for purchasing and device handling.
The FDA recall entries do not report adverse-event counts or establish how many, if any, patients were affected. The stated reason is: “Guidewires from the affected lots are more flexible than expected.” The FDA records the cause as component design or selection but gives no further detail about the difference in flexibility or specific patient outcomes.
The FDA defines Class II as a recall where use may cause temporary or medically reversible health consequences, or where the probability of serious consequences is remote. The classification alone does not report that a particular patient was harmed. Both listings remain open, which means the manufacturer has started the recall and not all affected products have been corrected or removed. See the FDA’s medical device recall information page and Enforcement Reports portal.